Discovery and development of Boceprevir, an HCV NS3 protease inhibitor, for the treatment of hepatitis C infection

被引：0
作者：
Howe, Anita [1 ]
机构：
[1] Merck Reserach Lab, Kenilworth, NJ 07033 USA
来源：
ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY | 2012年 / 243卷
关键词：
D O I：
暂无
中图分类号：
O6 [化学];
学科分类号：
0703 ;
摘要：
365-BIOL
引用
收藏
页数：1
相关论文
共 50 条
  • [31] Hepatitis C virus NS3 serine protease as a drug discovery target
    McPhee, F
    Yeung, KS
    Good, AC
    Meanwell, NA
    DRUGS OF THE FUTURE, 2003, 28 (05) : 465 - 488
  • [32] Boceprevir: A Protease Inhibitor for the Treatment of Chronic Hepatitis C
    Foote, Bryce S.
    Spooner, Linda M.
    Belliveau, Paul P.
    ANNALS OF PHARMACOTHERAPY, 2011, 45 (09) : 1085 - 1093
  • [33] Treatment of HCV infection with the novel NS3/4A protease inhibitors
    De Luca, Andrea
    Bianco, Claudia
    Rossetti, Barbara
    CURRENT OPINION IN PHARMACOLOGY, 2014, 18 : 9 - 17
  • [34] Solution conformations of the substrates and inhibitor of hepatitis C virus NS3 protease
    Lee, JH
    Bang, K
    Jung, JW
    Ahn, IA
    Ro, S
    Lee, W
    BULLETIN OF THE KOREAN CHEMICAL SOCIETY, 1999, 20 (03) : 301 - 306
  • [35] Resistance Analysis of the Hepatitis C Virus NS3 Protease Inhibitor Asunaprevir
    McPhee, Fiona
    Friborg, Jacques
    Levine, Steven
    Chen, Chaoqun
    Falk, Paul
    Yu, Fei
    Hernandez, Dennis
    Lee, Min S.
    Chaniewski, Susan
    Sheaffer, Amy K.
    Pasquinelli, Claudio
    ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2012, 56 (07) : 3670 - 3681
  • [36] The therapeutic potential of NS3 protease inhibitors in HCV infection
    Goudreau, N
    Llinàs-Brunet, M
    EXPERT OPINION ON INVESTIGATIONAL DRUGS, 2005, 14 (09) : 1129 - 1144
  • [37] Discovery of a Potent and Selective Noncovalent Linear Inhibitor of the Hepatitis C Virus NS3 Protease (BI 201335)
    Llinas-Brunet, Montse
    Bailey, Murray D.
    Goudreau, Nathalie
    Bhardwaj, Punit K.
    Bordeleau, Josee
    Boes, Michael
    Bousquet, Yves
    Cordingley, Michael G.
    Duan, Jiamin
    Forgione, Pat
    Garneau, Michel
    Ghiro, Elise
    Gorys, Vida
    Goulet, Sylvie
    Halmos, Ted
    Kawai, Stephen H.
    Naud, Julie
    Poupart, Marc-Andre
    White, Peter W.
    JOURNAL OF MEDICINAL CHEMISTRY, 2010, 53 (17) : 6466 - 6476
  • [38] Discovery of GS-9451: An acid inhibitor of the hepatitis C virus NS3/4A protease
    Sheng, X. Christopher
    Appleby, Todd
    Butler, Thomas
    Cai, Ruby
    Chen, Xiaowu
    Cho, Aesop
    Clarke, Michael O.
    Cottell, Jeromy
    Delaney, William E.
    Doerffler, Edward
    Link, John
    Ji, Mingzhe
    Pakdaman, Rowchanak
    Pyun, Hyung-Jung
    Wu, Qiaoyin
    Xu, Jie
    Kim, Choung U.
    BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2012, 22 (07) : 2629 - 2634
  • [39] Discovery of MK-5172, a Macrocyclic Hepatitis C Virus NS3/4a Protease Inhibitor
    Harper, Steven
    McCauley, John A.
    Rudd, Michael T.
    Ferrara, Marco
    DiFilippo, Marcello
    Crescenzi, Benedetta
    Koch, Uwe
    Petrocchi, Alessia
    Holloway, M. Katharine
    Butcher, John W.
    Romano, Joseph J.
    Bush, Kimberly J.
    Gilbert, Kevin F.
    McIntyre, Charles J.
    Nguyen, Kevin T.
    Nizi, Emanuela
    Carroll, Steven S.
    Ludmerer, Steven W.
    Burlein, Christine
    DiMuzio, Jillian M.
    Graham, Donald J.
    McHale, Carolyn M.
    Stahlhut, Mark W.
    Olsen, David B.
    Monteagudo, Edith
    Cianetti, Simona
    Giuliano, Claudio
    Pucci, Vincenzo
    Trainor, Nicole
    Fandozzi, Christine M.
    Rowley, Michael
    Coleman, Paul J.
    Vacca, Joseph P.
    Summa, Vincenzo
    Liverton, Nigel J.
    ACS MEDICINAL CHEMISTRY LETTERS, 2012, 3 (04): : 332 - 336
  • [40] Potent novel inhibitors against hepatitis C virus NS3 (HCV NS3 GT-3a) protease domain
    Ikram, Saima
    Ahmad, Jamshaid
    Rehman, Irshad-Ur
    Durdagi, Serdar
    JOURNAL OF MOLECULAR GRAPHICS & MODELLING, 2020, 101
12345